These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2938943)

  • 1. Antibiotic-induced bacterial cell lysis: a therapeutic dilemma.
    Shenep JL
    Eur J Clin Microbiol; 1986 Feb; 5(1):11-2. PubMed ID: 2938943
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.
    Cohen J; McConnell JS
    Eur J Clin Microbiol; 1986 Feb; 5(1):13-7. PubMed ID: 3009177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-induced endotoxin release from bacteria and its clinical significance.
    Kirikae T; Nakano M; Morrison DC
    Microbiol Immunol; 1997; 41(4):285-94. PubMed ID: 9159401
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic-induced release of endotoxin: a reappraisal.
    Hurley JC
    Clin Infect Dis; 1992 Nov; 15(5):840-54. PubMed ID: 1445982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
    Cirioni O; Giacometti A; Ghiselli R; Bergnach C; Orlando F; Silvestri C; Mocchegiani F; Licci A; Skerlavaj B; Rocchi M; Saba V; Zanetti M; Scalise G
    Antimicrob Agents Chemother; 2006 May; 50(5):1672-9. PubMed ID: 16641434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.
    Dofferhoff AS; Nijland JH; de Vries-Hospers HG; Mulder PO; Weits J; Bom VJ
    Scand J Infect Dis; 1991; 23(6):745-54. PubMed ID: 1815338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.
    Mehtar S; Drabu Y; Blakemore P
    Eur J Clin Microbiol; 1986 Apr; 5(2):248-51. PubMed ID: 2941293
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymyxin B for endotoxin removal in sepsis.
    Cavaillon JM
    Lancet Infect Dis; 2011 Jun; 11(6):426-7. PubMed ID: 21616454
    [No Abstract]   [Full Text] [Related]  

  • 9. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.
    Periti P; Mazzei T
    Int J Antimicrob Agents; 1999 Jul; 12(2):97-105. PubMed ID: 10418753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septic shock from descending necrotizing mediastinitis - combined treatment with IgM-enriched immunoglobulin preparation and direct polymyxin B hemoperfusion: a case report.
    Pota V; Passavanti MB; Sansone P; Pace MC; Peluso F; Fiorelli A; Aurilio C
    J Med Case Rep; 2018 Mar; 12(1):55. PubMed ID: 29499757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-controlled active release of photocaged ciprofloxacin for lipopolysaccharide-targeted drug delivery using dendrimer conjugates.
    Wong PT; Tang S; Mukherjee J; Tang K; Gam K; Isham D; Murat C; Sun R; Baker JR; Choi SK
    Chem Commun (Camb); 2016 Aug; 52(68):10357-60. PubMed ID: 27476878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
    Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.
    Trautmann M; Scheibe C; Wellinghausen N; Holst O; Lepper PM
    Chemotherapy; 2010; 56(5):364-70. PubMed ID: 20926860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.
    Viljanen P; Käyhty H; Vaara M; Vaara T
    Can J Microbiol; 1986 Jan; 32(1):66-9. PubMed ID: 3008971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic strategy during septic shock].
    Carlet J
    Presse Med; 2006 Mar; 35(3 Pt 2):528-32. PubMed ID: 16550154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outer membrane as the penetration barrier against mupirocin in gram-negative enteric bacteria.
    Vaara M
    J Antimicrob Chemother; 1992 Feb; 29(2):221-2. PubMed ID: 1506338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases].
    Svetukhin AM; Blatun LA; Ukhin SA
    Antibiot Khimioter; 2005; 50(2-3):64-72. PubMed ID: 16308942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.